174 related articles for article (PubMed ID: 37502542)
1. Retracted: Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9841518. PubMed ID: 37502542
[TBL] [Abstract][Full Text] [Related]
2. Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma.
Wang F; Bi J; Yi C; Zhang Y; Zhang Y; Yue Q
Contrast Media Mol Imaging; 2022; 2022():7376588. PubMed ID: 35655721
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Identification of
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9876978. PubMed ID: 37564808
[TBL] [Abstract][Full Text] [Related]
4. High expression of the ferroptosis-associated MGST1 gene in relation to poor outcome and maladjusted immune cell infiltration in uterine corpus endometrial carcinoma.
Yan J; Ye G; Shao Y
J Clin Lab Anal; 2022 Apr; 36(4):e24317. PubMed ID: 35218676
[TBL] [Abstract][Full Text] [Related]
5. Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.
Ouyang D; Li R; Li Y; Zhu X
Med Sci Monit; 2019 Oct; 25():7998-8010. PubMed ID: 31650984
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Clinical Value of PPM1G Gene in Survival Prognosis and Immune Infiltration of Hepatocellular Carcinoma.
And Biomechanics AB
Appl Bionics Biomech; 2023; 2023():9862929. PubMed ID: 37946818
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9759467. PubMed ID: 38094384
[TBL] [Abstract][Full Text] [Related]
8. RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
Geng R; Zheng Y; Zhao L; Huang X; Qiang R; Zhang R; Guo X; Li R
Front Genet; 2020; 11():595733. PubMed ID: 33324448
[TBL] [Abstract][Full Text] [Related]
9.
Zhao Q; Chen G; Yang X; Wang T; Yuan S; Meng Q
Comb Chem High Throughput Screen; 2023; 26(2):330-338. PubMed ID: 35379118
[TBL] [Abstract][Full Text] [Related]
10. Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer.
Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
J Clin Lab Anal; 2022 Apr; 36(4):e24315. PubMed ID: 35244291
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9834327. PubMed ID: 37860371
[TBL] [Abstract][Full Text] [Related]
12. Construction of the novel immune risk scoring system related to CD8
Zhang G; Yin Z; Fang J; Wu A; Chen G; Cao K
Cancer Cell Int; 2023 Jun; 23(1):124. PubMed ID: 37349706
[TBL] [Abstract][Full Text] [Related]
13. Elevated Expression of Gamma-Glutamyl Hydrolase Is Associated With Poor Prognosis and Altered Immune Signature in Uterine Corpus Endometrial Carcinoma.
Yu C; Qi H; Zhang Y; Zhao W; Wu G
Front Genet; 2021; 12():764194. PubMed ID: 35082830
[TBL] [Abstract][Full Text] [Related]
14. Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma.
Wu Q; Tian R; Liu J; Ou C; Li Y; Fu X
Front Immunol; 2023; 14():1139126. PubMed ID: 36936912
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive landscape of the functions and prognostic value of RNA binding proteins in uterine corpus endometrial carcinoma.
Yao Y; Liu K; Wu Y; Zhou J; Jin H; Zhang Y; Zhu Y
Front Mol Biosci; 2022; 9():962412. PubMed ID: 36262474
[No Abstract] [Full Text] [Related]
16. Retracted: SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship.
And Biomechanics AB
Appl Bionics Biomech; 2023; 2023():9895406. PubMed ID: 37946808
[TBL] [Abstract][Full Text] [Related]
17. FAT2 mutation is associated with better prognosis and responsiveness to immunotherapy in uterine corpus endometrial carcinoma.
Wang Z; Xing L; Huang Y; Han P
Cancer Med; 2023 Feb; 12(3):3797-3811. PubMed ID: 36812126
[TBL] [Abstract][Full Text] [Related]
18. Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma.
Zhou C; Li C; Yan F; Zheng Y
Cancer Cell Int; 2020 Nov; 20(1):541. PubMed ID: 33292199
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma.
Pei LP; Zhang YZ; Li GY; Sun JL
Front Genet; 2022; 13():890591. PubMed ID: 35719366
[No Abstract] [Full Text] [Related]
20. The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer.
Liu W; Sun L; Zhang J; Song W; Li M; Wang H
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33782686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
